491 results
8-K
EX-99.1
ABT
Abbott Laboratories
17 Apr 24
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
7:36am
of the webcast will be available later in the day.
-- more --
Page 7 of 15
— Private Securities Litigation Reform Act of 1995 —
A Caution Concerning … Forward-Looking Statements
Some statements in this news release may be forward-looking statements for purposes of the Private Securities Litigation
8-K
EX-99.1
yva00 r7vou
24 Jan 24
Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook
7:36am
8-K
EX-99.1
mxunbfpx3
18 Oct 23
Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
7:37am
8-K
EX-99.1
6be0yhkdn84hh87ii37
20 Jul 23
Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business
8:29am
8-K
EX-99.1
9kevhtwq3dw ba6w3
19 Apr 23
Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business
7:25am
PX14A6G
ai3l41
10 Apr 23
Letter to shareholders
11:53am
8-K
EX-99.1
fr3 8h808akywf
19 Oct 22
Abbott Reports Third-Quarter 2022 Results and Raises
7:58am
8-K
31gkl 4wjjlss
19 Oct 22
Abbott Reports Third-Quarter 2022 Results and Raises
7:58am